Building for Regulated Industries: Lessons from Pharma Tech

Building for Regulated Industries: Lessons from Pharma Tech

When most software founders think about markets, they gravitate toward consumer apps or horizontal B2B tools. Regulated industries—pharmaceutical, medical devices, healthcare, financial services—often get overlooked. The perception is that they're slow, bureaucratic, and resistant to change.

That perception is partly true. But it misses the opportunity.

After building Cohera for pharmaceutical compliance, I've learned that regulated industries offer something rare in software: genuine moats, long-term customer relationships, and the chance to build products that have real impact on how essential industries operate.

Here's what I've learned about building for regulated industries.

Why Regulated Industries Are Different

Compliance isn't a feature—it's the product.

In a typical SaaS company, you build the product first and worry about compliance (SOC 2, GDPR, etc.) when customers start asking. In regulated industries, this approach fails spectacularly.

When a pharmaceutical company evaluates software, their first questions aren't about features. They're about:

• How do you maintain audit trails?
• How do you handle electronic signatures?
• Where is data stored? Is it encrypted at rest and in transit?
• Can you provide validation documentation?
• Have you been audited by regulators?

If you can't answer these questions satisfactorily, the conversation ends. You won't get a chance to demo your beautiful UI or explain your innovative features.

This means compliance must be foundational, not bolted on. The architecture decisions you make on day one determine whether you can serve regulated industries at all.

Understanding the Regulatory Landscape

Different regulated industries have different requirements, but there are common themes:

For pharmaceuticals (GxP):

• 21 CFR Part 11 (FDA electronic records and signatures)
• EU GMP Annex 11 (computerized systems)
• ALCOA+ principles (data integrity)
• Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), Good Clinical Practice (GCP)

For medical devices:

• 21 CFR Part 820 (Quality System Regulation)
• EU MDR/IVDR (Medical Device Regulation)
• ISO 13485 (Quality management for medical devices)

Common enterprise requirements:

• SOC 2 Type II (security controls)
• ISO 27001 (information security management)
• HIPAA (health information privacy)
• GDPR (data protection)

These aren't just checkboxes. Each represents months of work to implement, document, and maintain. But they're also moats—once you've done the work, competitors can't easily follow.

ALCOA+ as a Design Philosophy

The ALCOA+ framework for data integrity is actually a useful design philosophy for any regulated software:

• Attributable: Every action links to a person. Who created this? Who approved it? Who changed it?
• Legible: Data must be readable and understandable. Forever. Think about what "legible" means for data created 20 years ago.
• Contemporaneous: Records created when events occur, not reconstructed later. Timestamps matter enormously.
• Original: The source of truth is preserved. Copies and printouts aren't originals.
• Accurate: Data reflects what actually happened. Validation and verification are continuous.

And the "+" additions:

• Complete: All data is captured, including failed attempts and corrections.
• Consistent: Data tells the same story across systems.
• Enduring: Records persist for required retention periods (often decades).
• Available: Authorized users can access data when needed.

When you design with ALCOA+ in mind, you end up building systems that are more trustworthy, auditable, and maintainable than you would otherwise.

The 21 CFR Part 11 Primer

If you're building for pharma, you'll hear about "Part 11" constantly. Here's what it actually requires:

Electronic records must:

• Be protected from unauthorized access
• Maintain complete audit trails showing who changed what, when
• Have controls to prevent unauthorized changes
• Allow electronic searching and reporting

Electronic signatures must:

• Be unique to one individual
• Not be reusable
• Be verifiable
• Be legally binding as handwritten signatures

Audit trails must:

• Be computer-generated
• Be independent (not easily modifiable)
• Record the date and time of actions
• Record the identity of operators
• Record the nature of changes (old value, new value)

This sounds straightforward, but the devil is in implementation. What happens when a user corrects a mistake? How do you handle system clock changes? What if someone needs to sign on behalf of someone else during an emergency?

Each edge case needs a documented, defensible answer.

Sales Cycles and Customer Relationships

Selling to regulated industries requires patience:

Sales cycles are long. A typical enterprise pharmaceutical deal takes 6-18 months from first contact to signed contract. This includes:

• Initial discovery and demo
• Security questionnaire (often 200+ questions)
• Legal and procurement review
• IT and compliance team evaluation
• Pilot or proof of concept
• Validation planning
• Contract negotiation

Budgets are annual. Missing a budget cycle can delay a deal by a year. You need to understand your customer's fiscal year and procurement process.

Multiple stakeholders. The person who will use your product daily isn't the person who signs the contract. You need buy-in from:

• End users (who need the features)
• IT (who need security assurance)
• Quality/Compliance (who need regulatory confidence)
• Procurement (who need favorable terms)
• Finance (who need budget approval)
• Legal (who need acceptable contracts)

The upside: Once you're in, you're in. Customer relationships in regulated industries tend to be long-term. The switching cost is high (re-validation alone can take months), and customers who trust you will expand the relationship over time.

Building Trust

Trust is earned slowly in regulated industries:

Compliance certifications matter. SOC 2 Type II, ISO 27001, and similar certifications signal that you take security seriously and have been independently verified.

Validation packages help. Pharmaceutical customers need to validate your software for their specific use. Providing validation documentation (IQ/OQ/PQ templates, risk assessments, user requirements specifications) dramatically reduces their implementation burden.

Reference customers are essential. Pharma companies talk to each other. A reference call with a satisfied customer at a peer company is worth more than any marketing collateral.

Transparency builds credibility. Share your security practices, incident response procedures, and data handling policies openly. Companies that seem defensive or secretive raise red flags.

Technical Architecture Considerations

Data residency matters. Different regulations require data to stay within certain jurisdictions. Your architecture needs to support this without fragmenting the product experience.

Audit trails are everywhere. Everything that could matter in an investigation needs to be logged. But logging isn't enough—logs need to be tamper-evident, searchable, and retained for the required periods (often 7-10 years or longer).

Electronic signatures require workflow. You can't just store who clicked "approve." You need to capture authentication, present the content being signed, record the timestamp, and maintain the connection between signature and content.

Integrations are inevitable. Regulated companies run many systems. Your product will need to integrate with legacy systems, often via imperfect APIs or even file exports. Design for this from the start.

The Opportunity

Despite the challenges, regulated industries offer real opportunities for software founders:

The problems are significant. Pharmaceutical companies spend billions on compliance activities. Even small efficiency improvements have substantial value.

The moats are real. Compliance certifications, validation packages, customer relationships, and domain expertise create durable competitive advantages.

The market is underserved. Most software companies avoid regulated industries. The incumbent solutions are often legacy systems built decades ago.

The impact matters. Software that helps pharmaceutical companies operate more efficiently ultimately helps them develop and deliver medicines faster. That's meaningful work.

Advice for Founders

If you're considering building for regulated industries:

1. Hire domain experts early. You need people who understand how these industries actually work, not just the technical requirements.

2. Budget for compliance. SOC 2 audits, security tools, compliance consulting—these costs add up. Build them into your financial plan from the start.

3. Start talking to customers before you build. The sales cycle is long, but early conversations shape what you build. Don't wait until you have a product.

4. Be patient with revenue. Long sales cycles mean you need more runway than typical SaaS. Make sure your investors understand this.

5. Build relationships, not just products. In regulated industries, trust matters more than features. Be reliable, responsive, and honest.

The regulated industry opportunity isn't for everyone. But for founders willing to do the hard work, it offers the chance to build something durable and meaningful.